Delta Np73 expression in thyroid neoplasms originating from follicular cells

Pathology

Volumn 38, Issue 3, 2006, Pages 205-209

  Ito, Yasuhiro ^a   Uramoto, Hidetaka ^b   Funa, Keiko ^c   Yoshida, Hiroshi ^a   Jikuzono, Tomoo ^a   Asahi, Shuji ^a   Higashiyama, Takuya ^a   Tomoda, Chisato ^a   Takamura, Yuuki ^a   Miya, Akihiro ^a   Kobayashi, Kaoru ^a   Matsuzuka, Fumio ^a   Kuma, Kanji ^a   Miyauchi, Akira ^a  

^a KUMA HOSPITAL   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Delta Np73; Immunohistochemistry; Thyroid carcinoma

Indexed keywords

ISOPROTEIN; PROTEIN P73;

ADULT; AGED; ANAPLASTIC CARCINOMA; ARTICLE; CANCER INVASION; CANCER SIZE; FOLLICULAR CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PAPILLARY CARCINOMA; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SCORING SYSTEM; THYROID ADENOMA; THYROID FOLLICLE CELL; THYROID TUMOR; TISSUE SECTION; TUMOR VOLUME;

ADENOCARCINOMA, FOLLICULAR; ADENOMA; AGED; DISEASE PROGRESSION; DNA-BINDING PROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; NUCLEAR PROTEINS; THYROID GLAND; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 33745099534     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313020600696298     Document Type: Article

References (19)

1. Kaghad M, bonnet H, Yang A, et al. Monoallelic expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 1997; 90: 809-19.
2. Lo Cunsolo C, Casciano I, Banelli B, et al. Refined chromosomal localization of the putative tumor suppressor gene TP73. Cytogenet Cell Genet 1998; 82: 199-201.
3. Jost CA, Marin MC, Kaelin WG Jr. p73 is a simian [correction of human] p53-related protein that can induce apoptosis. Nature 1997; 389: 191-4.
4. Melino G, De Laurenzi V, Vousden KH. P73: Friend or foe in tumorigenesis. Nat Rev Cancer 2002; 2: 605-15.
5. De Laurenzi V, Catani MV, Terrinoni M, et al. Additional complexity in p73: induction by mitogens in lymphoid cells and identification of two new splicing variants epsilon and zeta. Cell Death Differ 1999; 6: 389-90.
6. Scaruffi P, Casciano I, Masiero L, et al. Lack of expression in mature B-ALL and identification of three new splicing variants restricted to pre-B and C-ALL indicate a role of p73 in B cell ALL differentiation. Leukemia 2000; 14: 518-9.
7. Levrero M, De Laurenzi V, Costanzo A, et al. Structure, function and regulation of p63 and p73. Cell Death Differ 1999; 6: 1146-53.
8. Stiewe T, Putzer BM. Role of p73 in malignancy: tumor suppressor or oncogene? Cell Death Differ 2002; 9: 237-45.
9. Stiewe T, Zimmermann S, Frilling A, et al. Transactivation-deficient delta TA-p73 acts as an Oncogene. Cancer Res 2002; 62: 3598-602.
10. Ito Y, Uruno R, Nakano K, et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 2003; 13: 381-8.
11. Ito Y, Tomoda C, Uruno T, et al. Ultrasound-detectable and anatomopathologically-detectable node metastasis in the lateral compartment as indicators of worse relapse-free survival in patients with papillary thyroid carcinoma. World J Surg 2005; 29: 917-20.
12. Falvo L, Catania A, Sorrenti S, et al. Prognostic significance of the age factor in the thyroid cancer: stastistical analysis. J Surg Oncol 2004; 88: 217-22.
13. Ito Y, Tomoda C, Uruno T, et al. Prognostic significance of extrathyroid extension of papillary thyroid carcinoma: massive but not minimal extension affects the relapse-free survival. World J Surg 2006; Jan 12: (Epub ahead of print).
14. Herrera MF, Lopez-Graniel CM, Saldana J, et al. Papillary thyroid carcinoma in Mexican patients: clinical aspects and prognostic factors. World J Surg 1996; 20: 94-99.
15. Aldinger KA, Samaan NA, Ibanez M, et al. Anaplastic carcinoma of the thyroid: a review of 84 cases of spindle and giant-cell carcinoma of the thyroid. Cancer 1978; 41: 2267-75.
16. Frasca F, Vella V, Aloisi A, et al. p73 tumor-suppressor activity is impaired in human thyroid cancer. Cancer Res 2003; 63: 5829-37.
17. Uramoto H, Sugio K, Oyama T, et al. Expression of delta Np73 predicts poor prognosis in lung cancer. Clin Cancer Res 2004; 10: 6905-11.
18. Casciano I, Mazzocco K, Boni L, et al. Expression of delta Np73 is a molecular maker for adverse outcome in neuroblastoma patients. Cell Death Differ 2002; 9: 246-51.
19. Ito T, Seyama T, Mizuno T, et al. Unique association of p53 mutations with undifferentiated but not with differentiated carcinomas of the thyroid gland. Cancer Res 1992; 52: 1369-73.